| Northeast Eye Care Associates, Pc | |
|
45 North Rd, Deerfield, NH 03037-1400 | |
| (603) 463-7373 | |
| (603) 463-7390 |
| Full Name | Northeast Eye Care Associates, Pc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 45 North Rd, Deerfield, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568495349 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| Provider Name | Susan E Fischer |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1811920689 PECOS PAC ID: 7315943164 Enrollment ID: I20061018000463 |
News Archive
Two common cancer drugs have been shown to both prevent and reverse type 1 diabetes in a mouse model of the disease, according to research conducted at the University of California, San Francisco.
Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, announced today at Heart Rhythm 2012, the Heart Rhythm Society's 33rd Annual Scientific Sessions, FDA approval and commercial launch for a full portfolio of pacing, defibrillation and left ventricular leads.
A new study appearing online today from the American Journal of Psychiatry finds that ketamine's acute antidepressant effect requires opioid system activation, the first time that a receptor site has been shown in humans to be necessary for any antidepressant's mechanism of action.
Mount Sinai Health System today began posting patient experience ratings for its doctors, becoming the largest academic health system in New York City to do so.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Northeast Eye Care Associates, Pc Po Box 428, Deerfield, NH 03037-0428 Ph: (603) 463-7373 | Northeast Eye Care Associates, Pc 45 North Rd, Deerfield, NH 03037-1400 Ph: (603) 463-7373 |
News Archive
Two common cancer drugs have been shown to both prevent and reverse type 1 diabetes in a mouse model of the disease, according to research conducted at the University of California, San Francisco.
Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, announced today at Heart Rhythm 2012, the Heart Rhythm Society's 33rd Annual Scientific Sessions, FDA approval and commercial launch for a full portfolio of pacing, defibrillation and left ventricular leads.
A new study appearing online today from the American Journal of Psychiatry finds that ketamine's acute antidepressant effect requires opioid system activation, the first time that a receptor site has been shown in humans to be necessary for any antidepressant's mechanism of action.
Mount Sinai Health System today began posting patient experience ratings for its doctors, becoming the largest academic health system in New York City to do so.
› Verified 3 days ago